Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-26-212473
Filing Date
2026-05-07
Accepted
2026-05-07 17:27:41
Documents
14
Effectiveness Date
2026-05-07

Document Format Files

Seq Description Document Type Size
1 S-8 d30467ds8.htm S-8 31163
2 EX-5.1 d30467dex51.htm EX-5.1 7927
3 EX-23.1 d30467dex231.htm EX-23.1 2477
4 EX-FILING FEES d30467dexfilingfees.htm   iXBRL EX-FILING FEES 15921
5 GRAPHIC g30467g0505080541146.jpg GRAPHIC 3694
  Complete submission text file 0001193125-26-212473.txt   190700

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d30467dexfilingfees_htm.xml XML 7393
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-295670 | Film No.: 26955001
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)